29 Sep Health, the new growth: monoclonal antibodies
Health, the new growth: Monoclonal antibodies
The technologies that have been developed to combat COVID have opened a new chapter for the development of drugs with high specificity, those that will allow us to get to...
26 Sep Health, the new growth: vaccines
A new technology, that based on mRNA, has shown that more effective and easily modifiable vaccines can be obtained. An uninteresting business, as it was the manufacture of vaccines has become...
11 Aug Evolución en los mercados en agosto y expectativas a corto plazo – Cierre de mercados
Con Alma Navarro, Radio Intereconomía. Conversación a mediados del mes de agosto con Miguel Ángel Temprano, CEO de Orfeo Capital, donde hablamos de cuál sigue siendo el pulso de los mercados a casi el final de la recta de vacaciones de los operadores americanos y europeos. En...
26 Jan The treatment. The Column of Miguel Ángel, 26th of January 2021
Scientists have obtained a vaccine in 8 months, but its logistics have not been resolved. But what about the treatment? There we have a great void....